Clinical Trial Update: A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors [Phase 3]

View source ↗

Summary

Phase 3 study evaluating intravenous iron isomaltoside 1000 (Monofer) administered by infusions in iron-deficient blood donors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency

Drugs mentioned

• Monofer (Ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Iron-deficiency | Phase 3 | Status: COMPLETED